You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 246 No. 2, July 10, 1981 TABLE OF CONTENTS
  JAMA
  •  Online Features
  CLINICAL CARDIOLOGY
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Digitalis in Heart Failure

Farewell to the Foxglove?

Marcis T. Sodums, MD; Richard A. Walsh, MD; Robert A. O'Rourke, MD

JAMA. 1981;246(2):158-160.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

AFTER more than 200 years of clinical use, the role of digitalis therapy in the management of acute and chronic congestive heart failure and its effectiveness compared with vasodilator therapy is being questioned. This controversy results from the difficulty in demonstrating the salutary effect of digitalis on overall cardiac performance, although the positive inotropic effect of digitalis on left ventricular function, both in the normal and depressed ventricle, has been well established.1,2 Accordingly, we will review the evidence for the beneficial effects of digitalis in acute (eg, myocardial infarction) and chronic heart failure and the relation between digitalis therapy and vasodilator therapy in these conditions.

Net cardiac pump performance results from the complex interaction of several opposing factors3 (Figure). Cardiac output is determined by the heart rate, left ventricular filling volume or preload, left ventricular afterload or resistance to left ventricular ejection (approximated by systolic blood pressure), and . . . [Full Text PDF of this Article]


Author Affiliations

From the Cardiology Division, Department of Medicine, The University of Texas Health Science Center, San Antonio.


Footnotes

This article is one of a series sponsored by the American Heart Association.

Reprint requests to Cardiology Division, Department of Medicine, The University of Texas Health Science Center, San Antonio, TX 78284 (Dr Sodums).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.